Study authors conducted a retrospective cohort study to compare CSII and MDI treatments on metabolic control, body mass index, and prevalence of severe hypoglycemia in children.
A higher risk for severe COVID-19 illness can be found among children with medical complexity and certain underlying conditions.
Researchers set out to determine the effect of stay-at-home orders in response to the COVID-19 pandemic on glycemic control in children with type 1 diabetes.
A significantly greater proportion of patients receiving exenatide once weekly met the <7% HbA1c glycemic target vs placebo, (31% vs 8.3%).
Researchers show that screening examinations are lacking for minority youths.
Although the rise in pediatric obesity predates the COVID-19 pandemic, stressors experienced during the pandemic exposed inequities in children’s health.
Only 29% of children and adolescents with gender dysphoria receive a gender dysphoria-related diagnosis, and 25% are prescribed gender-affirming hormonal treatment.
A team of researchers conducted genetic analyses of children and adolescents with primary adrenal insufficiency of unknown etiology to provide insight into diagnosing this and other related conditions.
The prevalence of psoriasis in children and adolescents with type 1 diabetes mellitus is investigated.
Childhood body mass index is associated with a later risk for eating disorders.
